Arcturus Therapeutics

Arcturus Therapeutics News & Events

Arcturus Therapeutics Acquires Cutting-Edge UNA Patent Estate from Marina

August 14, 2013

FOR IMMEDIATE RELEASE Arcturus Therapeutics Acquires Cutting-Edge UNA Patent Estate from Marina Biotech Novel intellectual property accelerates Arcturus’ development of best-in-class RNAi therapeutics SAN DIEGO, Calif., August 14, 2013 – Arcturus Therapeutics, Inc., an industry leader in RNAi technologies for the treatment of disease, today announced it has acquired the patented portfolio of Unlocked Nucleobase […]

Arcturus Therapeutics Raises $1.3 Million in Series Seed Funding

June 1, 2013

FOR IMMEDIATE RELEASE Financing from High Net-Worth Private Investors to Fuel RNAi Delivery Technologies for the Treatment of Disease SAN DIEGO, Calif., June 1, 2013 – Arcturus Therapeutics, Inc., an industry leader in RNAi technologies for the treatment of disease, today announced it has raised $1.3 million in a seed funding round led by multiple […]

Arcturus Therapeutics Begins Operations in Janssen Labs

March 4, 2013

FOR IMMEDIATE RELEASE RNAi Delivery Technology Specialists to Develop and Advance Novel Therapeutics for Rare Diseases SAN DIEGO, Calif., March 4, 2013 – Arcturus Therapeutics, Inc., a company on the forefront of research and development of RNAi technologies, today announced it is located in Janssen Labs at Janssen Research & Development, LLC in San Diego, […]